ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 82 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $111,000 | -35.8% | 21,790 | -22.0% | 0.00% | – |
| Q2 2019 | $173,000 | -26.1% | 27,936 | +1.9% | 0.00% | – |
| Q4 2018 | $234,000 | -72.8% | 27,411 | -36.2% | 0.00% | -100.0% |
| Q3 2018 | $860,000 | -25.8% | 42,959 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $1,159,000 | -57.2% | 44,879 | -60.4% | 0.00% | -66.7% |
| Q1 2018 | $2,705,000 | -38.3% | 113,188 | -12.5% | 0.00% | -25.0% |
| Q4 2017 | $4,385,000 | +57.1% | 129,391 | -1.9% | 0.00% | +33.3% |
| Q3 2017 | $2,792,000 | +46.9% | 131,887 | +21.3% | 0.00% | +50.0% |
| Q2 2017 | $1,901,000 | -2.8% | 108,709 | -2.8% | 0.00% | -33.3% |
| Q1 2017 | $1,956,000 | +162.2% | 111,788 | +153.3% | 0.00% | +200.0% |
| Q4 2016 | $746,000 | -39.4% | 44,134 | -41.2% | 0.00% | -50.0% |
| Q3 2016 | $1,232,000 | +12.4% | 75,099 | +3.8% | 0.00% | 0.0% |
| Q2 2016 | $1,096,000 | +4.8% | 72,376 | +0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,046,000 | – | 72,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |